Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN was delisted on the 3rd of October, 2022.
2 hedge funds and large institutions have $11.1M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $13.8M → $11.1M (-$2.79M)
71% less funds holding
Funds holding: 7 → 2 (-5)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIP
Liontrust Investment Partners
London,
United Kingdom
|
-$963K |
| 2 |
BC
Birchview Capital
Burlington,
Vermont
|
-$102K |
| 3 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
-$10K |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$3K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$1K |
BHVN Hedge Fund Activity: Q1 2023 in Review
2 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Biohaven Pharmaceutical Holding Company Ltd. (BHVN) for Q1 2023, worth a combined $11.1M — down 20% from $13.8M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BHVN and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Liontrust Investment Partners, cutting an estimated $963K.
- 2 institutional investors held Biohaven Pharmaceutical Holding Company Ltd. (BHVN) as of Q1 2023, down from 7 in Q4 2022.
- Funds reported $11.1M of Biohaven Pharmaceutical Holding Company Ltd. stock for Q1 2023, down 20% quarter-over-quarter.
- 0 funds opened new Biohaven Pharmaceutical Holding Company Ltd. positions in Q1 2023 and 5 closed out, a net change of -5 holders.
- The largest Biohaven Pharmaceutical Holding Company Ltd. seller in Q1 2023 was Liontrust Investment Partners, an estimated $963K sold.
Based on aggregated 13F filings for Q1 2023.